Home Knowledge Transfer Metabolic diseases

Metabolic diseases





Metabolic diseases


IQAC_052.  Treatment of non-alcoholic fatty liver disease

Treatment of non-alcoholic fatty liver diseases, in particular steatohepatitis, based on the use of a family of fatty acid amides with phenylalkylamines related compounds (OLHHA), which induces a reduction of liver damage.